US Over The Counter Healthcare Market

ID: MRFR/HC/50740-HCR 200 Pages Rahul Gotadki Last Updated: September 17, 2026
US Over The Counter Healthcare Market Research Report By Product Type (Analgesics, Cold and Cough Medicines, Digestive Health Products, Vitamins and Minerals, Other Healthcare Products), By Formulation (Tablets, Capsules, Liquids, Topical, Powders), By Distribution Channel (Pharmacies, Supermarkets, Online Retail, Health Stores, Convenience Stores) and By End User (Adults, Children, Elderly) -Forecast to 2035
US Over The Counter Healthcare Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)2.68%
2024 Market Size$ 50.83 Billion
2025 Market Size$ 52.19 Billion
2035 Market Size$ 68 Billion
Key Players
Johnson & Johnson
Procter & Gamble
Bayer
GlaxoSmithKline
Pfizer
Sanofi
Trends
  • Rise of Natural Products
  • Digital Health Integration
  • Increased Focus on Preventive Care
Opportunities
  • Aging Population
  • Growing Consumer Awareness
  • Expansion of Retail Channels
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Type (USD Billion)
      1. 4.1.1 Analgesics
      2. 4.1.2 Cold and Cough Medicines
      3. 4.1.3 Digestive Health Products
      4. 4.1.4 Vitamins and Minerals
      5. 4.1.5 Other Healthcare Products
    2. 4.2 Medical Device, BY Formulation (USD Billion)
      1. 4.2.1 Tablets
      2. 4.2.2 Capsules
      3. 4.2.3 Liquids
      4. 4.2.4 Topical
      5. 4.2.5 Powders
    3. 4.3 Medical Device, BY Distribution Channel (USD Billion)
      1. 4.3.1 Pharmacies
      2. 4.3.2 Supermarkets
      3. 4.3.3 Online Retail
      4. 4.3.4 Health Stores
      5. 4.3.5 Convenience Stores
    4. 4.4 Medical Device, BY End User (USD Billion)
      1. 4.4.1 Adults
      2. 4.4.2 Children
      3. 4.4.3 Elderly
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Johnson & Johnson (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Procter & Gamble (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Bayer (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 GlaxoSmithKline (GB)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Pfizer (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Sanofi (FR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Reckitt Benckiser (GB)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Novartis (CH)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 AbbVie (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY FORMULATION
    4. 6.4 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    5. 6.5 US MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
    9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    12. 6.12 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
    13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 MEDICAL DEVICE, BY FORMULATION, 2024 (% SHARE)
    15. 6.15 MEDICAL DEVICE, BY FORMULATION, 2024 TO 2035 (USD Billion)
    16. 6.16 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    17. 6.17 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
    18. 6.18 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
    19. 6.19 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY FORMULATION, 2025-2035 (USD Billion)
      3. 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. 7.2.4 BY END USER, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Over The Counter Healthcare Market Segmentation

US Over The Counter Healthcare Market By Type (USD Billion, 2025-2035)

  • Analgesics
  • Cold and Cough Medicines
  • Digestive Health Products
  • Vitamins and Minerals
  • Other US Over The Counter Healthcare Market Products

US Over The Counter Healthcare Market By Formulation (USD Billion, 2025-2035)

  • Tablets
  • Capsules
  • Liquids
  • Topical
  • Powders

US Over The Counter Healthcare Market By Distribution Channel (USD Billion, 2025-2035)

  • Pharmacies
  • Supermarkets
  • Online Retail
  • Health Stores
  • Convenience Stores

US Over The Counter Healthcare Market By End User (USD Billion, 2025-2035)

  • Adults
  • Children
  • Elderly

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.